Development of an in vitro suppression assay to assess functionality of therapeutic regulatory T cell for the treatment of rheumatoid arthritis

Dr Bea Vale De Melo E Oliveira B.ValeDeMeloEOliveira@napier.ac.uk
Associate

Dr Fern Findlay-Greene F.Findlay-Greene@napier.ac.uk
Research Technician

Dr Graham Wright G.Wright2@napier.ac.uk
Associate Professor

Ranking novel immune-modulating therapeutics for progression to clinical development Jul 2, 2018 - Sep 30, 2019
Ranking novel immune-modulating therapeutics for progression to clinical development

Investigating new therapies for osteoarthritis: a collaboration between ENU and Guangzhou Medical University, China May 1, 2018 - Aug 31, 2022
Investigating new therapies for osteoarthritis: a collaboration between ENU and Guangzhou Medical University, China

Osteoarthritis is the most important ageing-related disease, estimated to affect 13% of the UK population, and 8% of the Chinese po... Read More about Investigating new therapies for osteoarthritis: a collaboration between ENU and Guangzhou Medical University, China.

Developing an adoptive regulatory T cell therapy for the treatment of rheumatoid arthritis Mar 1, 2021 - Feb 28, 2024
The immune system contains a balance of cells that turn responses ‘on’ and those that turn it ‘off’. When this balance breaks down, inappropriate immune responses can attack healthy tissues causing autoimmune disease, such as rheuma... Read More about Developing an adoptive regulatory T cell therapy for the treatment of rheumatoid arthritis.

Using microfluidic biochips to develop a dynamic environment for pathogen infections Jun 5, 2023 - Jul 16, 2023
To give hands on experience for an undergraduate student in cell culture.